Nuvectis Pharma Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVCT is expected to report earnings to fall 22.86% to -27 cents per share on May 13
Q1'25
Est.
$-0.27
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.26
Q1'24
Beat
by $0.15
The last earnings report on February 25 showed earnings per share of -34 cents, missing the estimate of -25 cents. With 46.19K shares outstanding, the current market capitalization sits at 221.28M.